| Title |
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
|
|---|---|
| Published in |
New England Journal of Medicine, February 2018
|
| DOI | 10.1056/nejmoa1714448 |
| Pubmed ID | |
| Authors |
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo, Brian Turpin, Afshin Dowlati, Marcia S Brose, Leo Mascarenhas, Noah Federman, Jordan Berlin, Wafik S El-Deiry, Christina Baik, John Deeken, Valentina Boni, Ramamoorthy Nagasubramanian, Matthew Taylor, Erin R Rudzinski, Funda Meric-Bernstam, Davendra P S Sohal, Patrick C Ma, Luis E Raez, Jaclyn F Hechtman, Ryma Benayed, Marc Ladanyi, Brian B Tuch, Kevin Ebata, Scott Cruickshank, Nora C Ku, Michael C Cox, Douglas S Hawkins, David S Hong, David M Hyman |
X Demographics
The data shown below were collected from the profiles of 467 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 172 | 37% |
| Spain | 29 | 6% |
| France | 12 | 3% |
| Brazil | 11 | 2% |
| Mexico | 9 | 2% |
| Australia | 8 | 2% |
| United Kingdom | 7 | 1% |
| Canada | 6 | 1% |
| India | 5 | 1% |
| Other | 54 | 12% |
| Unknown | 154 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 255 | 55% |
| Scientists | 121 | 26% |
| Practitioners (doctors, other healthcare professionals) | 83 | 18% |
| Science communicators (journalists, bloggers, editors) | 7 | 1% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,196 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1196 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 180 | 15% |
| Other | 128 | 11% |
| Student > Ph. D. Student | 105 | 9% |
| Student > Master | 81 | 7% |
| Student > Bachelor | 81 | 7% |
| Other | 215 | 18% |
| Unknown | 406 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 369 | 31% |
| Biochemistry, Genetics and Molecular Biology | 148 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 51 | 4% |
| Agricultural and Biological Sciences | 46 | 4% |
| Chemistry | 17 | 1% |
| Other | 107 | 9% |
| Unknown | 458 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1153. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#13,101
of 25,928,676 outputs
Outputs from New England Journal of Medicine
#578
of 32,762 outputs
Outputs of similar age
#247
of 347,062 outputs
Outputs of similar age from New England Journal of Medicine
#9
of 267 outputs
Altmetric has tracked 25,928,676 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,762 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 123.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,062 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 267 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.